The Enterprise Sessions

Inspiring conversations,
personal stories, cutting-edge ideas

Leading the way

The Enterprise Sessions bring together a diverse mix of company founders and researchers who talk openly about their experiences forming spin-outs and start-ups, raising capital, building academic-industry partnerships and translating research discoveries into real-world impact.

Each episode aims to inform, inspire and challenge myths and stereotypes about research commercialisation and how businesses and universities can work together to tackle society's biggest challenges. 

Latest episode

Next-gen Probiotics for Gut Health with Dr Jenny Bailey

How can spin-outs leverage end-user feedback to refine products and validate markets?

Find out as Professor Michele Barbour talks to Dr Jenny Bailey, the CEO and Co-Founder of Ferryx, a biotech company focused on the commercial production of live bacterial products for the prevention and treatment of gastrointestinal inflammation in humans and animals.

 

Meet our host

Professor Michele Barbour is the Associate Pro Vice-Chancellor for Enterprise and Innovation at the University of Bristol, working to enhance, grow and promote the University’s interactions with business and industry.

Michele is also Professor of Biomaterials at the University of Bristol. She leads a research group and undergraduate biomaterials education within Bristol Dental School and is the academic founder of Pertinax Pharma – a spinout company specialising in novel biomaterials for the prevention and treatment of bacterial infection.

Previous episodes